Cooper Q4 revenue $927M (+9%); FY2024 guidance $3.81-3.88B; 4-for-1 stock split

COOPER COMPANIES, INC.

2023-FY EPS reported $5.91 revenue$3,593,200,000

Q4 GAAP diluted EPS $1.70 (+29%); non-GAAP diluted EPS $3.47 (+26%). FY GAAP EPS $5.91 (-24%), non-GAAP $12.81 (+3%).
CooperVision Q4 revenue $622.9M (+11% YoY) led by toric (+18%) and multifocal (+22%) lenses.
CooperSurgical Q4 revenue $304.2M (+6%), fertility up 12%.
FY2024 guidance: revenue $3.809-3.877B; non-GAAP EPS $13.60-14.00.
Board approved 4-for-1 stock split (effective Feb 16, 2024) and will end de minimis semi-annual dividend.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

COOPER COMPANIES, INC. reported fiscal year 2024 results: revenue $3,809 - $3,877 million, EPS $13.60 - $14.00 (non-GAAP diluted EPS). Guidance initiated.

Period: fiscal year 2024
Revenue: $3,809 - $3,877 million
EPS: $13.60 - $14.00 (non-GAAP diluted EPS)
Guidance: initiated
Result: guidance update

Exact text from the filing

The Company initiated its fiscal year 2024 financial guidance. Details are summarized as follows: • Fiscal 2024 total revenue of $3,809 - $3,877 million (organic growth of 6% to 8%) • CVI revenue of $2,548 - $2,594 million (organic growth of 7% to 9%) • CSI revenue of $1,261 - $1,283 million (organic growth of 4% to 6%) • Fiscal 2024 non-GAAP diluted earnings per share of $13.60 - $14.00

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

COOPER COMPANIES, INC. reported fiscal 2023 full year ended October 31, 2023 results: revenue $3,593.2 million.

Period: fiscal 2023 full year ended October 31, 2023
Revenue: $3,593.2 million
Result: reported results

Exact text from the filing

CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023. • Fourth quarter 2023 revenue of $927.1 million, up 9%, and up 9% organically. Fiscal year 2023 revenue of $3.6 billion, up 9%, or up 10% organically. • Fourth quarter 2023 GAAP diluted earnings per share (EPS) of $1.70, up 29%. Fiscal 2023 GAAP diluted EPS of $5.91, down 24%. • Fourth quarter 2023 non-GAAP diluted EPS of $3.47, up 26%. Fiscal 2023 non-GAAP diluted EPS of $12.81, up 3%.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

COOPER COMPANIES, INC. reported fiscal Q4 2023 ended October 31, 2023 results: revenue $927.1 million, EPS $1.70 (GAAP diluted EPS), $3.47 (non-GAAP diluted EPS).

Period: fiscal Q4 2023 ended October 31, 2023
Revenue: $927.1 million
EPS: $1.70 (GAAP diluted EPS), $3.47 (non-GAAP diluted EPS)
Result: reported results

Exact text from the filing

a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023. • Fourth quarter 2023 revenue of $927.1 million, up 9%, and up 9% organically. Fiscal year 2023 revenue of $3.6 billion, up 9%, or up 10% organically. • Fourth quarter 2023 GAAP diluted earnings per share (EPS) of $1.70, up

View on SEC.gov

Browse all earnings releases →

COOPER COMPANIES, INC. filing history →

Source: SEC EDGAR

accession 0000711404-23-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.